Neupogen 300 mg Vial Injection is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in those patients, who are treated with established cytotoxic chemotherapy for malignancy and myeloablative therapy. It is safe for adults and children. It is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events. Neupogen 300 mg Vial Injection reduces the risk of bacterial infections in HIV patients. We share glorious credentials in the list of top Suppliers and Exporters of Neupogen 300 mg Vial Injection from Maharashtra, India.